Martin Farlow MD, editor. Dr. Farlow of Indiana University School of Medicine receives research grant support from BristolMyersSquibb, Danone, Eisai, Elan, Eli Lilly, Genentech, Novartis, OctaPharma, Pfizer, Sanofi-Aventis and Sonexa; honorariums from Eisai, Forest Laboratories, Pfizer, and Novartis for speaking engagements; and fees from Accera, Astellas, Baxter, Bayer, DDB Remedy, Eisai, GE H...

of Oxford, Xoma; Research grants from Amgen, Celladon, Novartis, Sanofi-Aventis; Co-inventor of patents for the use of inhibitors of the renin–angiotensin system in selected survivors of MI with Novartis Pharmaceuticals AG and Boehringer Ingelheim, GMBH. Dr Pfeffer’s share of the licensing agreements is irrevocably transferred to charity. W.G.S.: Consulting:Menarini Farmaceutica Internazionale ...

Disclosures: Kathleen I. Pritchard: Consultant/advisory role: Novartis, Roche, AstraZeneca, GlaxoSmithKline, Amgen, Pfizer; Honoraria: GlaxoSmithKline, Amgen, Novartis, Roche, AstraZeneca, Pfizer; Expert testimony: AstraZeneca, Novartis, GlaxoSmithKline. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial...

Martin Farlow MD, editor. Dr. Farlow of Indiana University School of Medicine received research grant support from BristolMyersSquibb, Danone, Eisai, Elan, Eli Lilly, Genentech, Novartis, OctaPharma, Pfizer, Roche, Sanofi-Aventis, and Sonexa; honorariums from Eisai, Forest Laboratories, Pfizer, and Novartis for speaking engagements; and fees from Accera, Alltech, Astellas, Baxter Healthcare, Ba...